Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment

Publisher： Karger

E-ISSN： 1662-6575|4|1|229-235

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.1, 2011-04, pp. : 229-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatal Palmar-Plantar Erythrodysesthesia after Clofarabine and Cytarabine Chemotherapy

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 151-153

Karger

Access to resources Recommend Favorite

Pyridoxine as Prophylactic Therapy for Palmar-Plantar Erythrodysesthesia Associated with Administration of Pegylated Liposomal Doxorubicin (Caelyx): A Single-Center Experience

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 277-278

Karger

Access to resources Recommend Favorite

Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib

By  

Oncology, Vol. 77, Iss. 5, 2009-11 ,pp. : 257-271

Karger

Access to resources Recommend Favorite

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 141-146

Karger

Access to resources Recommend Favorite

An exploratory study to identify risk factors for the development of capecitabine‐induced Palmar Plantar Erythrodysesthesia (PPE)

By  

JOURNAL OF ADVANCED NURSING, Vol. 71, Iss. 8, 2015-08 ,pp. : 1825-1832

John Wiley & Sons Inc

Access to resources Recommend Favorite